Taiwan · Delayed Price · Currency is TWD Health & Life Statistics
Total Valuation
Health & Life has a market cap or net worth of TWD 545.19 million. The enterprise value is 494.39 million.
| Market Cap | 545.19M |
| Enterprise Value | 494.39M |
Important Dates
The next estimated earnings date is Monday, May 11, 2026.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health & Life has 47.41 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 47.41M |
| Shares Outstanding | 47.41M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 23.56% |
| Owned by Institutions (%) | n/a |
| Float | 34.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 171.23 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.02 |
| EV / Sales | 1.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -132.19 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.61.
| Current Ratio | 2.39 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | -52.63 |
| Interest Coverage | -10.61 |
Financial Efficiency
Return on equity (ROE) is -17.28% and return on invested capital (ROIC) is -22.18%.
| Return on Equity (ROE) | -17.28% |
| Return on Assets (ROA) | -5.15% |
| Return on Invested Capital (ROIC) | -22.18% |
| Return on Capital Employed (ROCE) | -12.28% |
| Weighted Average Cost of Capital (WACC) | 5.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.63 |
Taxes
| Income Tax | -5.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.85% in the last 52 weeks. The beta is 0.39, so Health & Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -10.85% |
| 50-Day Moving Average | 12.37 |
| 200-Day Moving Average | 12.75 |
| Relative Strength Index (RSI) | 32.72 |
| Average Volume (20 Days) | 44,977 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Health & Life had revenue of TWD 398.05 million and -61.67 million in losses. Loss per share was -1.30.
| Revenue | 398.05M |
| Gross Profit | 70.12M |
| Operating Income | -63.41M |
| Pretax Income | -67.35M |
| Net Income | -61.67M |
| EBITDA | -52.94M |
| EBIT | -63.41M |
| Loss Per Share | -1.30 |
Balance Sheet
The company has 247.65 million in cash and 196.85 million in debt, with a net cash position of 50.80 million or 1.07 per share.
| Cash & Cash Equivalents | 247.65M |
| Total Debt | 196.85M |
| Net Cash | 50.80M |
| Net Cash Per Share | 1.07 |
| Equity (Book Value) | 320.57M |
| Book Value Per Share | 6.76 |
| Working Capital | 287.39M |
Cash Flow
In the last 12 months, operating cash flow was 3.18 million and capital expenditures -6.92 million, giving a free cash flow of -3.74 million.
| Operating Cash Flow | 3.18M |
| Capital Expenditures | -6.92M |
| Depreciation & Amortization | 14.67M |
| Net Borrowing | -21.77M |
| Free Cash Flow | -3.74M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 17.62%, with operating and profit margins of -15.93% and -15.49%.
| Gross Margin | 17.62% |
| Operating Margin | -15.93% |
| Pretax Margin | -16.92% |
| Profit Margin | -15.49% |
| EBITDA Margin | -13.30% |
| EBIT Margin | -15.93% |
| FCF Margin | n/a |
Dividends & Yields
Health & Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | -11.31% |
| FCF Yield | -0.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 14, 2006. It was a forward split with a ratio of 1.0314.
| Last Split Date | Sep 14, 2006 |
| Split Type | Forward |
| Split Ratio | 1.0314 |
Scores
Health & Life has an Altman Z-Score of 1.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.49 |
| Piotroski F-Score | 3 |